Protacid® F120 is a sewage sludge-free, controlled-release agent ideal for pharmaceutical and nutraceutical applications. Additionally, it functions as an antacid, ensuring optimal performance in various formulations.
Chemical Name: Alginic Acid
CAS Number: 9005-32-7
Labeling Claims: APE-free, Allergen-free, Aluminum-free, Animal Products-free, Antibiotics-free, Artificial Flavor-Free, Azo Dyes-free, BSE-free, Bactericide-free, Benzoates-free, Bisphenol A-free, Butylated Hydroxyanisole-free, CMR Substances-free, Caffeine Free, Colorants-free, Conflict minerals-free, Dioxin-free, Endocrine Disruptor-free, Fungicide-free, GMO-free, Generally Recognized As Safe (GRAS), Glutamate-Free, Glycerin-free, Halal, Herbicide-free, Hormones-free, Impurities-free, Irradiation-free, Kosher, Latex-free, Melamine-free, Monosodium Glutamate (MSG)-free, NPE-free, Nanomaterials-free, Natural Latex Rubber-Free, Naturally Derived, Non-GMO, Not Listed In California Proposition 65, PAH-free, PFAS-Free, PFOA-free, PFOS-free, PHO (Partially Hydrogenated Oil)-Free, PVC-free, Palm Oil-free, Paraben-free, Pareve, Perfluorocarbon (PFC)-free, Pesticide-free, Phthalates-free, Plasticizer-free, Potassium-free, Preservative-free, Quaternary Ammonium Salt-Free, Radioactive-free, Residual Solvent -Free, Solvent-free, Steroids Free, Sugar-free, TSE-free, Tributyltin (TBT) - Free, Vegan, Vegetarian
Certifications & Compliance: British Pharmacopeia (BP), Clean Water Act (CWA) Certified, Comprehensive Environmental Response, Compensations & Liability Act (CERCLA), Doping-Free, EC No.1907/2006, EXCiPACT, European Pharmacopeia (Ph. Eur.), European Regulation 396/2005/EC, FCC Compliant, FDA 21 CFR 117, FDA 21 CFR 582.7724, FDA Compliant, FDA Food Safety Modernization Act (FSMA), FFDCA, FSSC 22000, GMP, Generally Recognized As Safe (GRAS), Halal, Halal Food Council of Europe, Hazard Analysis Critical Control Point (HACCP), ISO 14001, ISO 9000, ISO 9001, JECFA (FAO/WHO), Japan Pharmacopeia (JP), National Formulary (NF), Regulation (EU) No. 1169/2011, Regulation (EU) No. 231/2012, United States Pharmacopeia (USP), cGMP
